Editorial: What we aim for

Editorial: What we aim for

W hat is the level of quality and impact that we aim for in articles published in EMPH? This is an interdisciplinary journal that addresses a broad audience. Interdisciplinary work is often thought to suffer from a lack of rigor because it can escape the scrutiny that referees habitually apply to work in core disciplines. That is not what we intend here. We hold interdisciplinary work to a high...

Editorial: Keratoconus – What We Do Not Know

Diagnostic and therapeutic challenges for dermatologists: What shall we do when we don’t know what to do?

What shall we do when we have done everything we could for the diagnosis and treatment of a patient, but were not successful? What shall we do when there is no definite treatment for a patient? What shall we do when we have no diagnosis or treatment for a patient? Some useful suggestions are presented here to get rid of these situations.

Editorial: What Is Brain Mapping?

G20 World Brain Mapping Initiative (Neuroscience/N-20) is Putting Brain Mapping on the top of Global Economic Issues The Society for Brain Mapping, Therapeutics, and Brain Mapping Foundation are propelling therapeutic advances in Nano-Neurosurgery, Nano-Bio-Electronics, Artificial Intelligence, Neuro-Supercomputing and ‘cross-pollination’ among the bio-medical sciences and engine...

Editorial: Prostate Cancer: What We Know and What We Would Like to Know

Cancer research has undergone radical changes over the last few years. The issue today is no longer the amount of molecular, cellular, and clinical information available, but how to handle it. Systems biology is the latest in a series of innovative strategies driven by technological advances that have provided us with a suite of “omics” (1). Technology advancements have enabled comprehensive ch...